Publicaciones en colaboración con investigadores/as de Hospital Vall d'Hebron (43)

2024

  1. Early use of teduglutide in paediatric patients with intestinal failure is associated with a greater response rate: a multicenter study

    European Journal of Pediatrics, Vol. 183, Núm. 8, pp. 3173-3182

  2. First-line Management of Metastatic Urothelial Cancer: Current and Future Perspectives After the EV-302 and CheckMate-901 Studies

    Clinical Genitourinary Cancer

  3. Taurolidine lock in pediatric patients with intestinal failure. A practical guideline from the Spanish Society of Pediatric Gastroenterology, Hepatology and Nutrition (SEGHNP)

    Nutricion Hospitalaria, Vol. 41, Núm. 3, pp. 702-705

2023

  1. PTEN Loss Confers Resistance to Anti–PD-1 Therapy in Non–Small Cell Lung Cancer by Increasing Tumor Infiltration of Regulatory T Cells

    Cancer Research, Vol. 83, Núm. 15, pp. 2513-2526

  2. Practical aspects of PD-L1 assessment in the treatment of urothelial carcinoma: Consensus of the uropathology group of the SEAP

    Revista Espanola de Patologia, Vol. 56, Núm. 4, pp. 261-270

2022

  1. High-dose radiotherapy and risk-adapted androgen deprivation in localised prostate cancer (DART 01/05): 10-year results of a phase 3 randomised, controlled trial

    The Lancet Oncology, Vol. 23, Núm. 5, pp. 671-681

2021

  1. 10-Year Results of a Phase III Randomized Trial of High-Dose Radiotherapy and Risk-Adapted Androgen Deprivation in Localized Prostate Cancer

    International journal of radiation oncology, biology, physics, Vol. 111, Núm. 3, pp. S77

  2. Prognostic value of testosterone castration levels following androgen deprivation and high-dose radiotherapy in localized prostate cancer: Results from a phase III trial

    Radiotherapy and Oncology, Vol. 160, pp. 115-119

2020

  1. Experience With Teduglutide in Pediatric Short Bowel Syndrome: First Real-life Data

    Journal of pediatric gastroenterology and nutrition, Vol. 71, Núm. 6, pp. 734-739

2019

  1. Prostate pathology recommendations from the Uropathology working group of the Spanish Society of Pathology

    Revista Espanola de Patologia, Vol. 52, Núm. 3, pp. 167-177

2018

  1. The prognostic impact of additional intrathoracic findings in patients with cancer-related pulmonary embolism

    Clinical and Translational Oncology, Vol. 20, Núm. 2, pp. 230-242

2017

  1. Clinical features and short-term outcomes of cancer patients with suspected and unsuspected pulmonary embolism: The EPIPHANY study

    European Respiratory Journal, Vol. 49, Núm. 1

  2. Estimación del coste de la nutrición parenteral domiciliaria en España

    Nutricion Hospitalaria, Vol. 34, Núm. 2, pp. 271-276

  3. Monitorización de la nutrición parenteral pediátrica

    Nutricion Hospitalaria

  4. Nutrición parenteral domiciliaria en españa 2016; informe del grupo de nutrición artificial domiciliaria y ambulatoria nadya

    Nutricion Hospitalaria, Vol. 34, Núm. 6, pp. 1497-1501

  5. Pediatric parenteral nutrition: Clinical practice guidelines from the Spanish Society of Parenteral and Enteral Nutrition (SENPE), the Spanish Society of Pediatric Gastroenterology, Hepatology and Nutrition (SEGHNP) and the Spanish Society of Hospital Pharmacy (SEFH)

    Nutricion Hospitalaria, Vol. 34, Núm. 3, pp. 745-758

  6. Performance of the clinical index of stable febrile neutropenia (CISNE) in different types of infections and tumors

    Clinical and Translational Oncology, Vol. 19, Núm. 3, pp. 386-395

  7. Predicting serious complications in patients with cancer and pulmonary embolism using decision tree modelling: The EPIPHANY Index

    British Journal of Cancer, Vol. 116, Núm. 8, pp. 994-1001

  8. Prognostic value of computed tomography pulmonary angiography indices in patients with cancer-related pulmonary embolism: Data from a multicenter cohort study

    European Journal of Radiology, Vol. 87, pp. 66-75

  9. Registro del Grupo NADYA-SENPE de nutrición enteral domiciliaria en España, años 2014 y 2015

    Nutricion Hospitalaria, Vol. 34, Núm. 1, pp. 15-18